Roivant Sciences Director Ilan Oren Receives Annual Equity Awards
Roivant Sciences Ltd.
Subscribe to track ROIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filing: Roivant Sciences Ltd. ($ROIV) Insider: Ilan Oren (Director) Transaction Date: September 16, 2026 Action: Grant / Award Securities: 5,054 Common Shares (RSUs) + 10,531 Stock Options Price: $0.00 Direct Holdings Post-Transaction: 123,680 Common Shares Significance: Low (Routine Annual Director Equity Compensation)
Comprehensive Analysis
Executive Summary
On September 18, 2026, Roivant Sciences Ltd. ($ROIV) director Ilan Oren reported the receipt of annual equity compensation awarded on September 16, 2026. The awards comprise 5,054 Restricted Stock Units (RSUs) and 10,531 stock options with an exercise price of $39.57 per share.
Transaction Breakdown
- Non-Derivative Securities: Granted 5,054 RSUs at $0.00 per share under the Company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy. Direct common share ownership increased to 123,680 shares.
- Derivative Securities: Granted 10,531 stock options to purchase Common Shares at an exercise price of $39.57 per share, expiring September 15, 2036.
- Vesting Terms: Both awards vest 100% on September 16, 2027, subject to continued service as a director.
Market & Trading Significance
This transaction represents routine annual board compensation rather than open-market buying or selling. Because it is standard equity compensation governed by the non-employee director compensation plan, it does not provide an actionable signal regarding management's view on stock valuation and has low market impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.